Cart
sales@molnova.com
SU5402
CAS No. 215543-92-3
SU5402( SU5402 | SU-5402 | SU 5402 )
Catalog No. M17435 CAS No. 215543-92-3
SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 62 | In Stock |
|
| 5MG | 56 | In Stock |
|
| 10MG | 86 | In Stock |
|
| 25MG | 161 | In Stock |
|
| 50MG | 262 | In Stock |
|
| 100MG | 368 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSU5402
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.
-
DescriptionSU5402 is a potent and selective vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR) inhibitor (IC50 values are 0.02, 0.03, 0.51 and > 100 μ M at VEGFR2, FGFR1, PDGFR β and EGFR respectively).
-
In Vitro——
-
In Vivo——
-
SynonymsSU5402 | SU-5402 | SU 5402
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorFGFR1| PDGFRβ| VEGFR2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number215543-92-3
-
Formula Weight296.32
-
Molecular FormulaC17H16N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 30 mg/mL; 101.24 mM
-
SMILESCC1=CNC(=C1CCC(=O)O)/C=C\2/C3=CC=CC=C3NC2=O
-
Chemical Name(Z)-3-(4-methyl-2-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid.
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
FRAX1036
FRAX-1036 is a effective and selective PAK1 inhibitor.
-
ICA-105574
ICA-105574 is an activator of hERG that binds to the channel to remove inactivation, thus increasing peak current amplitude and shortening the action potential. It also modulates activation kinetics of the channel.
-
(Rac)-JBJ-04-125-02
JBJ-04-125-02 is effective as a single agent in both in vitro and in vivo models of EGFR-mutant lung cancer.
